The Enterprise Value as of June 2026 (TTM) for Candel Therapeutics, Inc. (CADL) is 276.91M

According to Candel Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 276.91M. This represents a change of 64.75% compared to the average of 168.08M of the last 4 quarters.

Candel Therapeutics, Inc. (CADL) Historical Enterprise Value (quarterly & annually)

How has CADL Enterprise Value performed in the past?

The mean historical Enterprise Value of Candel Therapeutics, Inc. over the last ten years is 109.54M. The current 276.91M Enterprise Value has changed 25.18% with respect to the historical average. Over the past ten years (40 quarters), CADL's Enterprise Value was at its highest in in the September 2024 quarter at 221.87M. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Candel Therapeutics, Inc. (CADL) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Candel Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Candel Therapeutics, Inc. (CADL) Average Enterprise Value

How has CADL Enterprise Value performed in the past?

The current Enterprise Value of Candel Therapeutics, Inc. (CADL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Candel Therapeutics, Inc. (CADL) Enterprise Value vs. Peers

How is CADL’s Enterprise Value compared to its peers?

Candel Therapeutics, Inc.’s Enterprise Value is greater than Mereo BioPharma Group plc (12.46M), greater than Immutep Limited (-1323749.00), less than Capricor Therapeutics, Inc. (1.10B), greater than ProQR Therapeutics N.V. (63.64M), less than Contineum Therapeutics, Inc. Class A Common Stock (430.95M), greater than Genelux Corporation (104.57M), greater than Aldeyra Therapeutics, Inc. (56.68M), less than Kyverna Therapeutics, Inc. (329.49M), greater than Editas Medicine, Inc. (193.08M), less than Cabaletta Bio, Inc. (400.61M),

Build a custom stock screener for Candel Therapeutics, Inc. (CADL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Candel Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Candel Therapeutics, Inc. (CADL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Candel Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.